Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd Williamson

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal of the Medical Association of Georgia|July 17, 2012
What's up with the cost of health insurance?M Todd Williamson
Journal of the Medical Association of Georgia|April 14, 2009
2008 MAG Presidential Inaugural addressM Todd Williamson
Modern Healthcare|September 9, 2010
Grappling with a leviathan. Right to contract provides needed counterbalance to government power in healthcareM Todd Williamson
Journal of the Medical Association of Georgia|June 19, 2009
U.S. House Energy and Commerce Committee Subcommittee on Health testimonyM Todd Williamson
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
A pharmacoeconomic model comparing two long-acting treatments for overactive bladderLes Noe, Russell Becker, Todd Williamson, et al.
Managed Care Interface|December 3, 2004
The implications of poor medication persistence with treatment for overactive bladderLes Noe, Robyn Sneeringer, Bimal Patel, et al.
American Health & Drug Benefits|June 20, 2018
Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based StudyTodd Williamson, Wendy Y Cheng, Nora McCormick, et al.
Journal of the Medical Association of Georgia|February 6, 2010
Health care payment reformM Todd Williamson, David Cook, Joe Bailey, et al.
Journal of Occupational and Environmental Medicine|April 24, 2003
Prevalence of arthritis and associated joint disorders in an employed population and the associated healthcare, sick leave, disability, and workers' compensation benefits cost and productivity loss of employersLamont Muchmore, Wendy D Lynch, Harold H Gardner, et al.
Journal of Comparative Effectiveness Research|August 22, 2022
Comparative effectiveness of larotrectinib versus entrectinib for the treatment of metastatic <i>NTRK</i> gene fusion cancersKangho Suh, Josh J Carlson, Fang Xia, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of the Medical Association of Georgia|July 17, 2012
What's up with the cost of health insurance?M Todd Williamson
Journal of the Medical Association of Georgia|April 14, 2009
2008 MAG Presidential Inaugural addressM Todd Williamson
Modern Healthcare|September 9, 2010
Grappling with a leviathan. Right to contract provides needed counterbalance to government power in healthcareM Todd Williamson
Journal of the Medical Association of Georgia|June 19, 2009
U.S. House Energy and Commerce Committee Subcommittee on Health testimonyM Todd Williamson
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
A pharmacoeconomic model comparing two long-acting treatments for overactive bladderLes Noe, Russell Becker, Todd Williamson, et al.
Managed Care Interface|December 3, 2004
The implications of poor medication persistence with treatment for overactive bladderLes Noe, Robyn Sneeringer, Bimal Patel, et al.
American Health & Drug Benefits|June 20, 2018
Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based StudyTodd Williamson, Wendy Y Cheng, Nora McCormick, et al.
Journal of the Medical Association of Georgia|February 6, 2010
Health care payment reformM Todd Williamson, David Cook, Joe Bailey, et al.
Journal of Occupational and Environmental Medicine|April 24, 2003
Prevalence of arthritis and associated joint disorders in an employed population and the associated healthcare, sick leave, disability, and workers' compensation benefits cost and productivity loss of employersLamont Muchmore, Wendy D Lynch, Harold H Gardner, et al.
Journal of Comparative Effectiveness Research|August 22, 2022
Comparative effectiveness of larotrectinib versus entrectinib for the treatment of metastatic <i>NTRK</i> gene fusion cancersKangho Suh, Josh J Carlson, Fang Xia, et al.
Pageof 4